Guj. Inject(Ker)

Guj._Inject(Ker)29 Apr 2024

Pharmaceuticals

₹

+0.31 (+1.98%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Guj. Inject(Ker)

Guj. Inject(Ker)

Pharmaceuticals

Guj._Inject(Ker)29 Apr 2024

₹

+0.31 (+1.98%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
26-Apr-2024	BC	Trading members of the Exchange are hereby informed that the under mentioned new securities of Gujarat Inject (Kerala) Ltd. (Scrip Code - 524238) are listed and permitted to trade on the Exchange wit	29-Apr-2024
24-Apr-2024	BC	Trading members of the Exchange are hereby informed that the under mentioned new securities of Gujarat Inject (Kerala) Ltd. (Scrip Code - 524238) are listed and permitted to trade on the Exchange wit	25-Apr-2024
24-Apr-2024	BC	Trading members of the Exchange are hereby informed that the under mentioned new securities of Gujarat Inject (Kerala) Ltd. (Scrip Code - 524238) are listed and permitted to trade on the Exchange wit	25-Apr-2024
05-Feb-2024	BC	GUJARAT INJECT (KERALA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve & take on record the Unaudited Fin	13-Feb-2024
08-Feb-2024	BC	Allotment of warrants of Face value of Rs. 10.00 on preferential issue basis	08-Feb-2024

No Rights has been declared by Guj._Inject(Ker)

Book Closure

Record Date	Split Date	Purpose
29-Apr-2024	-	Trading members of the Exchange are hereby informed that the under mentioned new securities of Gujarat Inject (Kerala) Ltd. (Scrip Code - 524238) are listed and permitted to trade on the Exchange wit
25-Apr-2024	-	Trading members of the Exchange are hereby informed that the under mentioned new securities of Gujarat Inject (Kerala) Ltd. (Scrip Code - 524238) are listed and permitted to trade on the Exchange wit
25-Apr-2024	-	Trading members of the Exchange are hereby informed that the under mentioned new securities of Gujarat Inject (Kerala) Ltd. (Scrip Code - 524238) are listed and permitted to trade on the Exchange wit
13-Feb-2024	-	GUJARAT INJECT (KERALA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 inter alia to consider and approve & take on record the Unaudited Fin
08-Feb-2024	-	Allotment of warrants of Face value of Rs. 10.00 on preferential issue basis

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Gujarat Inject (Kerala) Ltd ₹16.00(+0.31/1.98%)	16.00	+0.31	22.48	103.82	400.00	2.69
Astrazeneca Pharma India Ltd ₹5,556.10(+140.70/2.60%)	5,556.10	+140.70	13,890.25	74.79	87.09	21.21
Bliss GVS Pharma Ltd ₹124.45(+1.85/1.51%)	124.45	+1.85	1,302.88	61.27	19.09	1.33
Cipla Ltd ₹1,407.55(-1.85/-0.13%)	1,407.55	-1.85	113,644.88	53.64	34.56	4.39
Abbott India Ltd ₹26,277.60(+412.75/1.60%)	26,277.60	+412.75	55,839.90	17.43	48.74	17.96
Amrutanjan Health Care Ltd ₹709.40(+28.55/4.19%)	709.40	+28.55	2,050.92	17.07	46.61	7.83

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	0.22	0.00	0.15	0.00	0.10	0.03
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.22	0.00	0.15	0.00	0.10	0.03
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.04	0.02	0.00	0.03	0.00	0.40
Total Income	0.25	0.02	0.15	0.03	0.10	0.43
Total Expenditure	0.25	0.01	0.12	0.02	0.10	0.40
PBIDT	0.01	0.02	0.04	0.01	0.00	0.04
Interest	0.00	0.00	0.00	0.00	0.00	0.00
PBDT	0.01	0.02	0.04	0.01	0.00	0.04
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.00	0.00	0.01	0.00	0.00	0.01
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	0.00	0.01	0.03	0.01	0.00	0.03
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	0.00	0.01	0.03	0.01	0.00	0.03

EPS (Unit Curr.)	0.01	0.03	0.06	0.01	0.00	0.06
EPS (Adj) (Unit Curr.)	0.01	0.03	0.06	0.01	0.00	0.06
Calculated EPS (Unit Curr.)	0.01	0.03	0.06	0.01	0.00	0.06
Calculated EPS (Adj) (Unit Curr.)	0.01	0.03	0.06	0.01	0.00	0.06
Calculated EPS (Ann.) (Unit Curr.)	0.04	0.10	0.23	0.05	0.02	0.22
Calculated EPS (Adj) (Ann.) (Unit Curr.)	0.04	0.10	0.23	0.05	0.02	0.22
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	4.88	4.88	4.88	4.88	4.88	4.88
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	4.55	0.00	26.67	0.00	0.00	133.33
PBDTM(%)	4.55	0.00	26.67	0.00	0.00	133.33
PATM(%)	0.00	0.00	20.00	0.00	0.00	100.00

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	4.88	4.88	4.88	4.88	4.88	4.88
Reserves Total	-5.72	-5.76	-5.77	-5.66	-5.66	-5.66
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	-0.84	-0.88	-0.89	-0.78	-0.78	-0.78
Secured Loans	0.00	0.00	0.25	0.25	0.25	0.25
Unsecured Loans	0.61	0.73	0.44	0.34	0.34	0.34
Total Debt	0.61	0.73	0.69	0.59	0.59	0.59
Total Liabilities	-0.23	-0.15	-0.20	-0.19	-0.19	-0.19
APPLICATION OF FUNDS :
Gross Block	0.00	0.00	0.00	0.00	0.00	0.00
Less : Accumulated Depreciation	0.00	0.00	0.00	0.00	0.00	0.00
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	0.00	0.00	0.00	0.00	0.00	0.00
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.00	0.00	0.00	0.00	0.00	0.00
Sundry Debtors	0.00	0.00	0.00	0.00	0.00	0.00
Cash and Bank	0.06	0.01	0.01	0.01	0.01	0.01
Loans and Advances	0.01	0.02	0.00	0.00	0.00	0.01
Total Current Assets	0.07	0.02	0.01	0.01	0.01	0.02
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	0.32	0.00	0.00	0.00	0.00	0.00
Provisions	0.21	0.21	0.21	0.20	0.20	0.20
Total Current Liabilities	0.53	0.21	0.21	0.20	0.20	0.20
Net Current Assets	-0.46	-0.18	-0.19	-0.19	-0.19	-0.18
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.00	0.00
Net Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Total Assets	-0.46	-0.18	-0.19	-0.19	-0.19	-0.18
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.01	0.01	0.01	0.01	0.01
Net Cash from Operating Activities	0.05	0.00	-0.11	0.00	0.00
Net Cash Used In Investing Activities	0.00	0.00	0.00	0.00	0.00
Net Cash Used In Financing Activities	0.00	0.00	0.10	0.00	0.00
Net Inc./Dec In Cash And Cash Equivalents	0.05	0.00	0.00	0.00	0.00
Cash And Cash Equivalents At End Of The Year	0.06	0.01	0.01	0.01	0.01

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

0.00%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

100.00%

**Promoter pledged shareholding 0.00%

About Gujarat Inject (Kerala) Ltd

Gujarat Inject (Kerala) Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 22.48 crores. It has reported a sales of Rs. 0.22 crores and a net profit of Rs. 0 crores for the quarter ended December 2018. The company management includes , Murli Shivshankaran Nair,Reena Mahatma,Narayansinh Padudansinh Chauhan,Gautam Keshavlal Chauhan (Gujarat Inject (Kerala) Ltd) among others.

Chairman

Registered office

Bldg No XVII/1103 Kanjikode,Sarayu Arcade Satrapadi,Palakkad,Kerala,678621

FAX :

Background

Incorporation Year1991

Face Value₹10

Market Lot1

How to buy Guj. Inject(Ker) shares on nse?

To buy Guj. Inject(Ker) shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Guj. Inject(Ker) share price today?

The Guj. Inject(Ker) shares price on nse is Rs.16 today.

What is the market cap of Guj. Inject(Ker) shares on BSE ?

The company has a market capitalization of Rs.22.48Cr

What is the PE & PB ratio of Guj. Inject(Ker) shares ?

PE is 400 and PB is 2.69

What is the 52 Week High and Low of Guj. Inject(Ker) shares?

Guj. Inject(Ker) stock price high: Rs.16.45 Guj. Inject(Ker) stock price low: Rs.6.72